Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,585 | 198 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $813.40 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $500.78 | 18 | $0 (2024) |
| PFIZER INC. | $456.98 | 36 | $0 (2024) |
| Novo Nordisk Inc | $297.70 | 19 | $0 (2024) |
| Lilly USA, LLC | $191.97 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $141.47 | 6 | $0 (2024) |
| Exact Sciences Corporation | $140.40 | 7 | $0 (2024) |
| Amgen Inc. | $128.52 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $116.68 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $112.23 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,958 | 105 | AstraZeneca Pharmaceuticals LP ($408.66) |
| 2023 | $1,106 | 71 | ABBVIE INC. ($375.94) |
| 2022 | $409.12 | 21 | ABBVIE INC. ($84.88) |
| 2021 | $112.23 | 1 | Janssen Pharmaceuticals, Inc ($112.23) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Oncology | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.56 | General |
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $47.51 | General |
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: DIABETES | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: Obesity | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: VACCINES | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Oncology | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 205 | 234 | $39,643 | $14,334 |
| 2022 | 7 | 260 | 295 | $36,186 | $15,090 |
| 2021 | 2 | 32 | 33 | $5,768 | $2,384 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 81 | $14,803 | $5,756 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 112 | $13,524 | $4,392 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $11,316 | $4,186 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 165 | $18,861 | $7,906 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $9,108 | $3,426 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 26 | $4,238 | $1,489 | 35.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $1,666 | $1,165 | 69.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 22 | $1,572 | $564.83 | 35.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $629.00 | $490.86 | 78.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 14 | $112.00 | $48.15 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $3,588 | $1,381 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 20 | $2,180 | $1,003 | 46.0% |
About Hannah Cummins
Hannah Cummins is a Family healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2021. The National Provider Identifier (NPI) number assigned to this provider is 1285301408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hannah Cummins has received a total of $3,585 in payments from pharmaceutical and medical device companies, with $1,958 received in 2024. These payments were reported across 198 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,585).
As a Medicare-enrolled provider, Cummins has provided services to 497 Medicare beneficiaries, totaling 562 services with total Medicare billing of $31,808. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Indianapolis, IN
- Active Since 08/25/2021
- Last Updated 08/25/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1285301408
Products in Payments
- VRAYLAR (Drug) $778.40
- NURTEC ODT (Drug) $247.68
- FARXIGA (Drug) $221.66
- MOUNJARO (Drug) $166.24
- BREZTRI (Drug) $142.45
- Kerendia (Drug) $141.47
- Cologuard Collection Kit (Device) $140.40
- AIRSUPRA (Drug) $136.67
- EVENITY (Biological) $128.52
- XARELTO (Drug) $112.23
- PREVNAR 20 (Biological) $107.79
- OFEV (Drug) $81.97
- Wegovy (Drug) $78.11
- Ozempic (Drug) $78.09
- ELIQUIS (Drug) $65.56
- CAPLYTA (Drug) $64.04
- ACCRUFER (Drug) $61.01
- JARDIANCE (Drug) $60.44
- PAXLOVID (Drug) $44.71
- SHINGRIX (Biological) $43.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Indianapolis
Tina Sizemore, Fnp, FNP
Family — Payments: $700,167
Marla Moses, Fnp, FNP
Family — Payments: $90,175
Alicia Wettrick, Fnp, FNP
Family — Payments: $70,871
Deidre Arms, Cnp, CNP
Family — Payments: $24,993
Christine Balt, N.p, N.P
Family — Payments: $22,490
Jessica Taylor, Fnp, FNP
Family — Payments: $12,304